| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $370K | -71.6% | +7300.0% |
| Cost of Revenue | $312K | -74.8% | +6140.0% |
| Gross Profit | $58K | -6.5% | — |
| R&D Expense | $420K | -39.1% | -87.9% |
| SG&A Expense | $3.9M | -2.8% | -74.3% |
| Operating Income | -$4.4M | +9.4% | +78.4% |
| Pre-tax Income | -$7.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.7M | +387.2% | -27.1% |
| Accounts Receivable | $167K | -76.0% | — |
| Inventory | $1.0M | +190.5% | -66.3% |
| Current Assets | $7.3M | +128.1% | -41.5% |
| Total Assets | $11.1M | +63.5% | -30.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.6M | — | — |
| Investing Cash Flow | -$13K | — | — |
| Financing Cash Flow | $3.8M | — | — |
| -217.0% |
| Income Tax | $0 | — | — |
| Net Income | -$7.5M | -63.2% | -217.0% |
| EPS (Basic) | -$2.70 | -22.7% | -943.8% |
| EPS (Diluted) | -$2.70 | -22.7% | -943.8% |
| $10.6M |
| +21.5% |
| +81.0% |
| Long-term Debt | $12.9M | -0.8% | +8.0% |
| Total Liabilities | $23.9M | +8.7% | +13.2% |
| Stockholders' Equity | -$12.7M | +15.9% | -146.5% |